Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 18, 2018 - Issue 1
Submit an article Journal homepage
1,231
Views
38
CrossRef citations to date
0
Altmetric
Review

Treatment options for chorea

H. BashirParkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USAView further author information
&
J. JankovicParkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USACorrespondence[email protected]
View further author information
Pages 51-63 | Received 25 Sep 2017, Accepted 08 Nov 2017, Published online: 15 Nov 2017

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Roberta Bovenzi, Matteo Conti & Tommaso Schirinzi. (2023) Pharmacotherapy for Sydenham’s chorea: where are we and where do we need to be?. Expert Opinion on Pharmacotherapy 24:11, pages 1317-1329.
Read now
Luiz Paulo Bastos Vasconcelos, Marcelle Cristina Vasconcelos, Maria Do Carmo Pereira Nunes & Antonio Lucio Teixeira. (2019) Sydenham’s chorea: an update on pathophysiology, clinical features and management. Expert Opinion on Orphan Drugs 7:11, pages 501-511.
Read now
Hassaan Bashir. (2019) Emerging therapies in Huntington’s disease. Expert Review of Neurotherapeutics 19:10, pages 983-995.
Read now
Hassaan Bashir & Joseph Jankovic. (2018) Deutetrabenazine for the treatment of Huntington’s chorea. Expert Review of Neurotherapeutics 18:8, pages 625-631.
Read now

Articles from other publishers (34)

Tiago Magalhães, Cláudia Melo, Mafalda Sampaio, Ana Correia-Costa & Raquel Sousa. (2023) Hyperkinetic Movement Disorder in a Child. Pediatrics in Review 44:9, pages e24-e28.
Crossref
Karim Makhoul & Joseph Jankovic. (2023) Real-world experience with VMAT2 inhibitors in Tourette syndrome. Journal of Neurology 270:9, pages 4518-4522.
Crossref
Anuradha Baminiwatta & Christoph U. Correll. (2023) Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications. Frontiers in Psychiatry 14.
Crossref
Beatrice Heim & Klaus Seppi. (2023) Valbenazine as treatment for Huntington's disease chorea. The Lancet Neurology 22:6, pages 459-460.
Crossref
Yeşim Güzey Aras, Sena Boncuk Ulaş, Türkan Acar & Bilgehan Atılgan Acar. (2023) Hemiballism and chorea with acute/subacute onset: a retrospective series. Acta Neurologica Belgica 123:2, pages 591-597.
Crossref
Frank Schneider, Borje Darpo, Pippa S. Loupe, Hongqi Xue, Helena Knebel, Maria Gutierrez, Mark Forrest Gordon & Laura Rabinovich‐Guilatt. (2022) Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis. Clinical Pharmacology in Drug Development 12:1, pages 94-106.
Crossref
Stephanie Feleus, Malu van Schaijk, Raymund Roos & Susanne de Bot. (2022) The Many Faces of Huntington’s Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review. Journal of Personalized Medicine 12:4, pages 589.
Crossref
Mackenzie W. Ferguson, Connor J. Kennedy, Thulani H. Palpagama, Henry J. Waldvogel, Richard L. M. Faull & Andrea Kwakowsky. (2022) Current and Possible Future Therapeutic Options for Huntington’s Disease. Journal of Central Nervous System Disease 14, pages 117957352210925.
Crossref
Jie Wei & Yue Zhang. (2021) Hemichorea in a patient with ipsilateral cortical infarction: a case report. BMC Neurology 21:1.
Crossref
Arnaud Lapostolle, Timo Delion, Souraya Arnaud, Philippe Manceau & Bertrand Degos. (2021) Thrombocytopenia and agranulocytosis in a FXTAS choreic patient treated with tetrabenazine. Neurological Sciences 42:8, pages 3475-3477.
Crossref
Dutta Rajib. (2021) Multimodal treatment strategies in Huntington’s disease. Journal of Neuroscience and Neurological Disorders 5:2, pages 072-082.
Crossref
Yu-Jin Kim & Ha-Yeoung Min. (2021) The Mediation Effect of Self-Determination in the Relationships between Proactive Personality and Child Care Teacher’s Work Engagement. Journal of Families and Better Life 39:2, pages 79-90.
Crossref
Frank Schneider, David Stamler, Margaret Bradbury, Pippa S. Loupe, Edward Hellriegel, Donna S. Cox, Juha‐Matti Savola, Mark Forrest Gordon & Laura Rabinovich‐Guilatt. (2020) Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect. Clinical Pharmacology in Drug Development 10:6, pages 647-659.
Crossref
Shujun Chen, Tianyu Liang, Tao Xue, Shouru Xue & Qun Xue. (2021) Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Neurology 12.
Crossref
Hervé Javelot, Mylène Meyer, Solène Frismand & Coraline Hingray. (2021) Benefit of long-acting paliperidone in Huntington’s disease: a case report. International Clinical Psychopharmacology 36:2, pages 101-103.
Crossref
LeonardoAjuz do Prado Oliveira, IzabelaMara Martins Silveira, ThiagoRibeiro e Silva & DanielAlmeida do Valle. (2021) Carbamazepine-responsive chorea in a toddler with semilobar holoprosencephaly: Case report. Journal of Pediatric Neurosciences 16:4, pages 335.
Crossref
Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn & Jennifer Goldman. 2021. Principles and Practice of Movement Disorders. Principles and Practice of Movement Disorders 550 559.e4 .
Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn & Jennifer Goldman. 2021. Principles and Practice of Movement Disorders. Principles and Practice of Movement Disorders 401 417.e9 .
Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn & Jennifer Goldman. 2021. Principles and Practice of Movement Disorders. Principles and Practice of Movement Disorders 371 400.e14 .
Zixiao Yin, Yutong Bai, Hua Zhang, Huanguang Liu, Wenhan Hu, Fangang Meng, Anchao Yang & Jianguo Zhang. (2020) An individual patient analysis of the efficacy of using GPi-DBS to treat Huntington’s disease. Brain Stimulation 13:6, pages 1722-1731.
Crossref
Falaq Naz & Yasir Hasan Siddique. (2020) Human Brain Disorders: A Review. The Open Biology Journal 8:1, pages 6-21.
Crossref
Christine M. Stahl & Andrew Feigin. (2020) Medical, Surgical, and Genetic Treatment of Huntington Disease. Neurologic Clinics 38:2, pages 367-378.
Crossref
Maeve Greenberg, Nina Paddu, Siddhi Bhivandkar & Saeed Ahmed. (2020) Treating Depression and Suicidality in Huntington's Disease. Psychiatric Annals 50:2, pages 85-88.
Crossref
Steven Bellows & Joseph Jankovic. (2020) Treatment of dystonia and tics. Clinical Parkinsonism & Related Disorders 2, pages 12-19.
Crossref
Sanem Yilmaz & Jonathan W. Mink. (2020) Treatment of Chorea in Childhood. Pediatric Neurology 102, pages 10-19.
Crossref
Nicki Niemann & Joseph Jankovic. (2019) Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism & Related Disorders 67, pages 74-89.
Crossref
Pichet Termsarasab. (2019) Chorea. CONTINUUM: Lifelong Learning in Neurology 25:4, pages 1001-1035.
Crossref
J. Weaver, H. Sarva, D. Barone, S. Bobker, K. Bushara, A. Hiller, M. Ishii, J. Jankovic, S. Lakhani, K. Niotis, D.W. Scharre, P. Tuite, A. Stutz, C.M. Westhoff & R.H. Walker. (2019) McLeod syndrome: Five new pedigrees with novel mutations. Parkinsonism & Related Disorders 64, pages 293-299.
Crossref
Simone Migliore, Joseph Jankovic & Ferdinando Squitieri. (2019) Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?. Frontiers in Neurology 10.
Crossref
Mayur Chalia & Thyagarajan Subramanian. (2019) Type 2 Diabetes Presenting With Persistent Chorea. JAMA Neurology 76:3, pages 366.
Crossref
Claudia M. Testa & Joseph Jankovic. (2019) Huntington disease: A quarter century of progress since the gene discovery. Journal of the Neurological Sciences 396, pages 52-68.
Crossref
Mered Parnes, Hassaan Bashir & Joseph Jankovic. (2018) Is Benign Hereditary Chorea Really Benign? Brain‐Lung‐Thyroid Syndrome Caused by NKX2‐1 Mutations . Movement Disorders Clinical Practice 6:1, pages 34-39.
Crossref
April N. Sharp & Harvey S. Singer. (2018) Standard, Complementary, and Future Treatment Options for Tics. Current Developmental Disorders Reports 5:2, pages 101-107.
Crossref
Nicki Niemann & Joseph Jankovic. (2018) Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs 78:5, pages 525-541.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.